Tumour necrosis factor- (TNF-) levels and influence of −308 TNF- promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis

By Cuchacovich M   Ferreira L   Aliste M   Soto L   Cuenca J   Cruzat A   Gatica H   Schiattino I   Pérez C   Aguirre A   Salazar-Onfray F   Aguillón JC  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 4, 2004-07 ,pp. : 228-232

Informa Healthcare

Access to resources Recommend Favorite

Levels of TNF, TNF autoantibodies and soluble TNF receptors in patients with bronchial asthma

By Golikova Elena Alexeevna   Lopatnikova Julia Anatolievna   Kovalevskaya-Kucheryavenko Tatiana Vladimirovna   Nepomnyashih Vera Makarovna   Sennikov Sergey Vitalievich  

Journal of Asthma, Vol. 50, Iss. 7, 2013-09 ,pp. : 705-711

Informa Healthcare

Access to resources Recommend Favorite

Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis

By Tam Lai-Shan   Tomlinson Brian   Chu Tanya   Li Tena   Li Edmund  

Clinical Rheumatology, Vol. 26, Iss. 9, 2007-09 ,pp. : 1495-1498

Springer Publishing Company

Access to resources Recommend Favorite

TNF- −308 promoter polymorphism in patients with rheumatoid arthritis

By Pawlik A.   Florczak M.   Ostanek L.   Brzosko M.   Brzosko I.   Szklarz B. Gawronska  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 1, 2005-02 ,pp. : 22-26

Informa Healthcare

Access to resources Recommend Favorite

Changes in chemokines and their receptors in blood during treatment with the TNF inhibitor infliximab in patients with rheumatoid arthritis

By Eriksson C   Rantapää-Dahlqvist S   Sundqvist KG  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 4, 2013-08 ,pp. : 260-265

Informa Healthcare

Access to resources Recommend Favorite